Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 15, 2021, the board of directors, or the Board, of Pluristem
Therapeutics Inc., or the Company, appointed Prof. Varda Shalev and Mr. Doron
Birger to serve as members of the Board, effective immediately, each to hold
office until the next general meeting of shareholders of the Company at which
directors are being elected or as set forth in the Company's bylaws.
Prof. Shalev, age 62, has been serving as a professor at the department of
epidemiology at the medical school of Tel Aviv University, Israel since 2019.
She has also been serving as a member of the board of directors of BATM Advanced
Communications Ltd. since November 2018. She is the CMO OF Alike since May 2020.
Prof. Shalev established the Department of Medical Informatics at Maccabi Health
Care and was responsible for planning and developing its computerized medical
systems. She has pioneered the development of multiple disease registries to
support chronic disease management. She has also served as the director of
primary care division at Maccabi Health Care from October 2013 to June 2015 and
as the Chief Executive Officer of the research and innovation center (KSM
Institute and Maccabitech the epidemiological and clinical research arm of
Israel's Maccabi Healthcare Services) at Maccabi Health Care from July 2015 to
May 2020. Prof. Shalev holds an MD from Ben Gurion University, Israel, and an
MPH in Public Health Administration from Clark University, Massachusetts and her
Doc Fellowship in Medical Informatics from Johns Hopkins University.
Mr. Doron Birger, age 70, has been serving as the chairman of the board of
directors of Sight Diagnostic Ltd. since June 2014, Nurami Medical Ltd. since
April 2016, Ultrasight Medical Imaging Ltd. from June 2019 Intelicanna Ltd.
(TASE: INTL) from April 2021 and Matricelf Ltd. (TASE:MTLF ) from December 2020,
and as a director of IceCure Medical Ltd. (TASE: ICCM) since August 2012,
Vibrant Ltd. since December 2014, Hera Med Ltd. (ASX: HMD) since November 2019,
Citrine Global (OTC: CTGL) since March 2020, Kadimastem Ltd. (TASE: KDST) since
December 2020 and Netiv Ha'or, a subsidiary of the Israel Electric Corporation
Ltd. since March 2020 and as chairman and director in a variety of non-profit
organizations. Prior to that, Mr. Birger has served as member of the board of
directors of MCS Medical Compression Systems (DBN) Ltd. (TASE:MDCL) from March
2015 to May 2018, Mekorot National Water Company Ltd. from November 2015 to
November 2018, and chairman of the board of directors of Insulin Medical Ltd.
(TASE: INSL) from March 2016 to August 2017, IOPtima Ltd. from June 2012 to June
2019, MST Medical Surgical Technologies Ltd. from August 2009 to June 2019,
Highcon Ltd. from November 2014 to January 2018, Magisto Ltd. from September
2009 to July 2019, Real Imaging Ltd. from November 2018 to April 2019 and
Medigus Ltd. (Nasdaq and TASE: MDGS) from May 2015 to September 2018. Mr. Birger
holds a BA and MA in economics from the Hebrew University, Israel.
It has not been determined whether Prof. Shalev or Mr. Birger will be named to
any Board committees. As remuneration for their services as a directors, each of
Prof. Shalev and Mr. Birger will receive the same fees as the Company's other
non-executive directors, as described in the Company's Annual Report on Form
10-K for the fiscal year ended June 30, 2020.
There are no arrangements or understandings between either of Prof. Shalev or
Mr. Birger and any other persons pursuant to which she or he was appointed as a
member of the Board.
There are no family relationships between any of the Company's directors or
officers and either Prof. Shalev or Mr. Birger. There are no related party
transactions involving either Prof. Shalev or Mr. Birger that are reportable
under Item 404(a) of Regulation S-K.
1© Edgar Online, source Glimpses
PLURI INC. 